Atlas Trials

The Efficacy of APT Magnetic Resonance Imaging in Predicting the Efficacy of Bevacizumab in Recurrent Malignant Gliomas

Clinical trial NCT03180697 · UNKNOWN

Trial details

NCT number
NCT03180697
Sponsor
Zhujiang Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Diagnoses DiseaseGlioma of Brain
Start date
2017-06-03
Primary completion
2021-09-30
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.